methotrexate has been researched along with Cognition Disorders in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (5.06) | 18.7374 |
1990's | 10 (12.66) | 18.2507 |
2000's | 31 (39.24) | 29.6817 |
2010's | 34 (43.04) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, IJ | 3 |
Derwich, K; Jończyk-Potoczna, K; Karmelita-Katulska, K; Pawlak, M; Pilarczyk, J; Przepióra, A; Wachowiak, J; Zając-Spychała, O | 1 |
Bijttebier, P; D'Hooge, R; Danckaerts, M; Deprez, S; Elens, I; Labarque, V; Lemiere, J; Uyttebroeck, A; Van Gool, S | 1 |
Cole, PD; Gulinello, ME; Maxwell, RR; Spira, M; Wen, J; Wolf, AJ | 1 |
Whalley, K | 1 |
Gutmann, DH | 1 |
Geraghty, AC; Ghanem, RA; Gibson, EM; Goldstein, AK; Greenberg, ME; Greene, JJ; Longo, FM; Marton, RM; Monje, M; Ni, L; Ocampo, A; Paşca, SP; Yang, T | 1 |
Leake, I | 1 |
Donmez, S; Keystone, EC; Kisacik, B; Onat, AM; Pamuk, GE; Pamuk, ON; Pehlivan, Y; Sayarlioglu, M | 1 |
Briones, TL; Woods, J | 1 |
Huang, J; Tannock, IF; Winocur, G; Wojtowicz, JM | 1 |
Armstrong, FD; Bell, B; Brecher, ML; Chauvenet, AR; Chen, L; Duffner, PK; Helton, KJ | 1 |
Armstrong, FD; Bell, B; Brecher, ML; Chauvenet, AR; Duffner, PK; Helton, K | 1 |
Dietrich, J; Jordan, JT; Plotkin, S | 1 |
Boogerd, W; Loos, M; Schagen, SB; Seigers, R; Smit, AB; Van Tellingen, O | 1 |
Abe, S; Asashima, H; Ebe, H; Hagiwara, S; Hirota, T; Kondo, Y; Kurata, I; Matsumoto, I; Ogishima, H; Sumida, T; Suzuki, T; Takahashi, H; Tsuboi, H; Umeda, N; Yagishita, M | 1 |
Berrios, I; Ghiran, S; Ionete, C; Jun-O'Connell, A | 1 |
Bishop, MW; Brinkman, TM; Cheung, YT; Daryani, VM; Edelmann, MN; Hudson, MM; Kimberg, C; Krull, KR; Liu, W; Mulrooney, DA; Ness, KK; Robison, LL; Srivastava, DK; Stewart, CF | 1 |
Effinger, KE; Link, MP | 1 |
Jalali, N; Niemann, N; Rouah, E | 1 |
Merkley, CM; Tannock, IF; Winocur, G; Wojtowicz, JM | 1 |
Bhojwani, D; Brinkman, TM; Cheung, YT; Glass, JO; Hudson, MM; Hwang, SN; Krull, KR; Liu, W; Pui, CH; Reddick, WE; Robison, LL; Sabin, ND; Srivastava, D | 1 |
Derwich, K; Karmelita-Katulska, K; Pawlak, MA; Pilarczyk, J; Wachowiak, J; Zając-Spychała, O | 1 |
Ashford, JM; Cheng, C; Conklin, HM; Glass, JO; Jeha, S; Laningham, FH; Nassar, SL; Pui, CH; Reddick, WE; Zhou, Y | 1 |
Ehrlichman, RS; Gandal, MJ; Rudnick, ND; Siegel, SJ | 1 |
Buwalda, B; Coppens, CM; Koolhaas, JM; Schagen, SB; Seigers, R; van Dam, FS; van der Most, PJ | 1 |
Cole, PD; Gulinello, M; Li, Y; Vijayanathan, V | 1 |
Calabrese, C; Catananti, C; Mastropaolo, S; Onder, G; Silveri, MC | 1 |
Fardell, JE; Johnston, I; Logge, W; Vardy, J | 1 |
Chukoskie, L; Kamen, BA | 1 |
Binns, MA; Tannock, I; Winocur, G | 1 |
Ali, N; Cole, PD; Gulinello, M; Vijayanathan, V | 1 |
Abrey, LE; Correa, DD; Deangelis, LM; Deutsch, MB; Omuro, AM; Shi, W; Thaler, HT | 1 |
Biassoni, V; Casanova, M; Catania, S; Cefalo, G; Clerici, CA; Collini, P; Ferrari, A; Gandola, L; Luksch, R; Massimino, M; Meazza, C; Pallotti, F; Pecori, E; Podda, M; Poggi, G; Polastri, D; Pollo, B; Potepan, P; Riva, D; Schiavello, E; Seregni, E; Simonetti, F; Spreafico, F; Terenziani, M; Valentini, L | 1 |
Braszko, J; Grabowska, A; Holownia, A; Krawczuk-Rybak, M; Muszynska-Roslan, K; Protas, PT | 1 |
Boogerd, W; Muller, MJ; Rodenhuis, S; Rosenbrand, RM; Schagen, SB; van Dam, FS; van Rhijn, D | 1 |
Colosimo, C; Guzzetta, F; Iuvone, L; Mariotti, P; Riccardi, R; Ruggiero, A | 1 |
Fliessbach, K; Glasmacher, A; Helmstaedter, C; Klockgether, T; Kraus, JA; Pels, H; Schlegel, U; Schmidt-Wolf, I; Urbach, H | 1 |
O'Neill, BP | 1 |
Abrey, LE; Correa, DD; DeAngelis, LM; Glass, A; Shi, W; Thaler, H | 1 |
Bromberg, JE; Haaxma-Reiche, H; Harder, H; Holtel, H; Kluin-Nelemans, HC; Menten, J; Poortmans, P; van den Bent, MJ | 1 |
Abu-Saad, HH; Candel, MJ; Courtens, AM; de Jong, N; Schouten, HC | 1 |
Barrowman, NJ; Dunlap, H; Halton, JM; Hsu, E; Keene, DL; Kuehn, SM; Matzinger, MA; Montour-Proulx, I | 1 |
Althaus, A; Fliessbach, K; Glasmacher, A; Helmstaedter, C; Juergens, A; Klockgether, T; Linnebank, M; Pels, H; Schlegel, U; Schmidt-Wolf, IG; Urbach, H | 1 |
De Meyer, G; Mennes, M; Stiers, P; Uyttebroeck, A; Van Cool, SW; Vandenbussche, E; Vercruysse, G | 1 |
Boogerd, W; Hamburger, HL; Kreukels, BP; Ridderinkhof, KR; Schagen, SB; van Dam, FS | 1 |
Abrey, LE; Anderson, ND; Correa, D; DeAngelis, LM; Glass, A; Mason, WP | 1 |
Dodd, M; Dowling, G; Jansen, C; Kramer, J; Miaskowski, C | 1 |
Butler, RW; Haser, JK | 1 |
Chemmanam, T; Krishnamoorthy, T; Kuruvilla, A; Nair, MD; Radhakrishnan, VV; Raghavendra, S | 1 |
Beerling, W; Boogerd, W; Buwalda, B; Koolhaas, JM; Schagen, SB; Seigers, R; van Dam, FS; van Tellingen, O | 1 |
Callejas-Rubio, JL; Guerrero Fernández, M; Ortego-Centeno, N; Ríos Fernández, R; Serrano Falcón, MM | 1 |
Carey, M; Hockenberry, M; Kaemingk, K; Krull, K; Miketova, P; Moore, IM; Pasvogel, A | 1 |
Boogerd, W; Kreukels, BP; Ridderinkhof, KR; Schagen, SB; van Dam, FS | 1 |
Battin, M; Chessells, J; Christie, D; Leiper, AD; Neville, BG; Vargha-Khadem, F | 1 |
Bouffet, E; Doz, F; Gentet, JC; Mottolese, C; Plantaz, D; Ponvert, D; Roche, H; Stephan, JL; Thyss, A; Tron, P | 1 |
Butler, RW; Finlay, JL; Hill, JM; Meyers, PA; Steinherz, PG | 1 |
Finley, SM; Hobbie, WL; Hollen, PJ | 1 |
Boogerd, W; Bruning, PF; Lindeboom, J; Muller, MJ; Schagen, SB; van Dam, FS | 1 |
Kaleita, TA; MacLean, WE; Reaman, GH; Sather, HN; Whitt, JK | 1 |
Bode, U; Deckert-Schlüter, M; Fischer, HP; Glasmacher, A; Kleinschmidt, R; Oehring, R; Pels, H; Schlegel, U | 1 |
Holdaway, D; Lawrence, B; Raymond-Speden, E; Tripp, G | 1 |
Balzamo, M; Ceccaldi, M; de Roux-Serratrice, C; Disdier, P; Donnet, A; Félician, O; Gaudy, C; Granel, B; Manera, L; Pache, X; Raybaud, C; Serratrice, J; Swiader, L; Weiller, PJ | 1 |
De Seze, J; Ferriby, D; Ingrand, D; Mackowiak-Cordoliani, MA; Stojkovic, T; Vermersch, P | 1 |
Finke, J; Korfel, A; Schmidt-Wolf, I; Thiel, E | 1 |
Beck, JD; Hertzberg, H; Langer, T; Martus, P; Meier, W; Ottensmeier, H | 1 |
Deelman, BG; Kamps, WA; Kingma, A; Mooyaart, EL; Van Dommelen, RI; Wilmink, JT | 1 |
Kadan-Lottick, N; Neglia, JP | 1 |
Bagnasco, I; Bulgheroni, S; Cefalo, G; Gandola, L; Giannotta, M; Giorgi, C; Massimino, M; Nichelli, F; Pantaleoni, C; Riva, D; Saletti, V | 1 |
Andrykowski, MA; Brady, MJ; Gregg, ME; Henslee-Downey, PJ; Lamb, DG; Schmitt, FA | 1 |
Forio, I; Giralt, J; Olive, T; Ortega, JJ; Salvador, L; Verges, R | 1 |
Mulhern, RK; Ochs, J; Williams, JM; Williams, KS | 1 |
Howes, A; Kernan, WJ; Mullenix, PJ; Schunior, A; Tarbell, NJ; Tassinari, MS; Waber, DP | 1 |
Davis, KS; Williams, JM | 1 |
Brouwers, P; Fedio, P; Poplack, DG; Riccardi, R | 1 |
Harris, RF; Innes, EM; Kay, HE; Knapton, PJ; O'Sullivan, JP; Schwartz, FC; Stuart, J; Thompson, EN; Wells, DG | 1 |
Bluming, AZ; Carbone, PP; Fass, L; Morrow, RH; Ziegler, JL | 1 |
4 review(s) available for methotrexate and Cognition Disorders
Article | Year |
---|---|
A case of neurosarcoidosis secondary to treatment of etanercept and review of the literature.
Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Central Nervous System Diseases; Cognition Disorders; Etanercept; Female; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Sarcoidosis; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis | 2015 |
Potential mechanisms for chemotherapy-induced impairments in cognitive function.
Topics: Anemia; Animals; Antineoplastic Agents; Attention; Blood-Brain Barrier; Cognition Disorders; Cyclophosphamide; Doxorubicin; Encephalitis; Fluorouracil; Humans; Inflammation; Language; Learning; Memory; Menopause; Methotrexate; Neoplasms; Oncology Nursing; Paclitaxel; Psychomotor Performance; Spatial Behavior | 2005 |
Neurocognitive effects of treatment for childhood cancer.
Topics: Antineoplastic Agents; Brain Neoplasms; Child; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Developmental Disabilities; Humans; Injections, Spinal; Intellectual Disability; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2006 |
Central nervous system prophylactic treatment for childhood leukemia: neuropsychological outcome studies.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cognition Disorders; Combined Modality Therapy; Female; Humans; Infant; Intelligence Tests; Leukemia; Male; Meningeal Neoplasms; Methotrexate; Quality of Life; Radiotherapy; Stress, Psychological | 1986 |
9 trial(s) available for methotrexate and Cognition Disorders
Article | Year |
---|---|
Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cognition Disorders; Cytarabine; Dexamethasone; Female; Humans; Hydrocortisone; Incidence; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Seizures; Vincristine | 2017 |
Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Mastectomy; Mental Processes; Methotrexate; Middle Aged; Neoplasm Staging; Netherlands; Neuropsychological Tests; Predictive Value of Tests; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Survival Analysis; Time Factors | 2002 |
Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain; Brain Neoplasms; Cognition Disorders; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Nerve Fibers, Myelinated; Neuropsychological Tests; Prospective Studies; Psychomotor Performance; Quality of Health Care; Time; Treatment Outcome | 2005 |
Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
Topics: Antineoplastic Agents; Attention; Central Nervous System Neoplasms; Child; Cognition Disorders; Contraindications; Female; Humans; Injections, Spinal; Male; Mental Processes; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Psychological Tests; Radiotherapy; Survivors | 2005 |
Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cognition Disorders; Combined Modality Therapy; Disease-Free Survival; Feasibility Studies; Female; Humans; Infant; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Survival Analysis | 1995 |
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Attention; Breast Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Cyclophosphamide; Depression; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neuropsychological Tests; Quality of Life; Socioeconomic Factors | 1999 |
Intrathecal methotrexate affects cognitive function in children with medulloblastoma.
Topics: Adolescent; Age Factors; Antimetabolites, Antineoplastic; Cerebellar Neoplasms; Child; Child, Preschool; Cognition Disorders; Humans; Injections, Spinal; Magnetic Resonance Imaging; Medulloblastoma; Methotrexate; Neuropsychological Tests | 2002 |
Long-term neuropsychologic sequelae of childhood leukemia: comparison of two CNS prophylactic regimens.
Topics: Adolescent; Age Factors; Brain; Brain Neoplasms; Child; Cognition Disorders; Combined Modality Therapy; Cytarabine; Female; Humans; Intelligence; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis | 1992 |
Parental report of everyday cognitive abilities among children treated for acute lymphoblastic leukemia.
Topics: Adolescent; Brain Neoplasms; Child; Cognition Disorders; Cranial Irradiation; Female; Humans; Injections, Spinal; Intelligence Tests; Learning Disabilities; Male; Methotrexate; Neuropsychological Tests; Parents; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
66 other study(ies) available for methotrexate and Cognition Disorders
Article | Year |
---|---|
Neurocognitive Functioning in the AALL0232 Protocol.
Topics: Adrenal Cortex Hormones; Child; Cognition Disorders; Humans; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Brain; Cancer Survivors; Case-Control Studies; Chemoradiotherapy; Child; Cognition Disorders; Cranial Irradiation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Intelligence Tests; Magnetic Resonance Imaging; Male; Methotrexate; Neurotoxicity Syndromes; Organ Size; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Treatment Outcome; Young Adult | 2018 |
Neurocognitive Sequelae in Adult Childhood Leukemia Survivors Related to Levels of Phosphorylated Tau.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Biomarkers; Case-Control Studies; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neuropsychological Tests; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Survival Rate; Survivors; tau Proteins; Young Adult | 2017 |
Methotrexate causes persistent deficits in memory and executive function in a juvenile animal model.
Topics: Animals; Brain; Cell Proliferation; Cognition Disorders; Executive Function; Female; Folic Acid Antagonists; Homocysteine; Male; Memory Disorders; Methotrexate; Microglia; Pattern Recognition, Visual; Rats, Long-Evans; Recognition, Psychology; Spatial Memory | 2018 |
A glial contribution to 'chemobrain'.
Topics: Cognition Disorders; Cognitive Dysfunction; Humans; Methotrexate; Neuroglia | 2019 |
Clearing the Fog surrounding Chemobrain.
Topics: Cognition Disorders; Cognitive Dysfunction; Humans; Methotrexate | 2019 |
Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive Impairment.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Channelrhodopsins; Cognition Disorders; Disease Models, Animal; Humans; Immunosuppressive Agents; Luminescent Proteins; Membrane Glycoproteins; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelin Sheath; Oligodendrocyte Precursor Cells; Organic Chemicals; Protein-Tyrosine Kinases; Recognition, Psychology; Signal Transduction; Urea | 2019 |
Aberrant adaptive myelination in 'chemobrain'.
Topics: Cognition Disorders; Cognitive Dysfunction; Humans; Methotrexate | 2019 |
Do impaired memory, cognitive dysfunction and distress play a role in methotrexate-related neutropenia in rheumatoid arthritis patients? A comparative study.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Cognition Disorders; Female; Humans; Male; Memory Disorders; Methotrexate; Middle Aged; Neutropenia; Stress, Psychological | 2013 |
Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapy-related cognitive impairment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cognition Disorders; Corpus Callosum; Cyclophosphamide; Cytokines; Female; Fluorouracil; Inflammation; Methotrexate; Nerve Fibers, Myelinated; Random Allocation; Rats; Rats, Sprague-Dawley; Recognition, Psychology | 2014 |
Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats.
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Cognition Disorders; Cues; Dentate Gyrus; Doublecortin Domain Proteins; Doublecortin Protein; Female; Fluorouracil; Housing, Animal; Immunohistochemistry; Learning; Memory; Methotrexate; Microtubule-Associated Proteins; Motor Activity; Neurogenesis; Neuropeptides; Neuropsychological Tests; Rats, Long-Evans; Spatial Memory | 2014 |
Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A rep
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cognition Disorders; Female; Humans; Infant; Intelligence Tests; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prevalence; Risk Factors; Treatment Outcome | 2014 |
Inadequate folinic acid rescue after methotrexate causing neurocognitive and neuroradiological central nervous system late effects in children with acute lymphatic leukemia.
Topics: Cognition Disorders; Female; Humans; Leukoencephalopathies; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2014 |
In reply.
Topics: Cognition Disorders; Female; Humans; Leukoencephalopathies; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2014 |
Magnetic resonance imaging observations in primary central nervous system lymphoma.
Topics: Brain Neoplasms; Cerebral Ventricle Neoplasms; Cognition Disorders; Corpus Callosum; Female; Humans; Immunosuppressive Agents; Lateral Ventricles; Lymphoma, B-Cell; Methotrexate; Middle Aged; Stereotaxic Techniques; Treatment Outcome | 2014 |
Cognitive impact of cytotoxic agents in mice.
Topics: Animals; Antineoplastic Agents; Cognition; Cognition Disorders; Cytotoxins; Dose-Response Relationship, Drug; Fear; Fluorouracil; Male; Memory; Methotrexate; Mice; Mice, Inbred C57BL; Reaction Time | 2015 |
A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus successfully treated by corticosteroid and methotrexate.
Topics: Adrenal Cortex Hormones; Central Nervous System Diseases; Cognition Disorders; Comorbidity; Drug Therapy, Combination; Female; Humans; Hydrocephalus; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Recurrence; Rheumatic Nodule; Sarcoidosis; Treatment Outcome | 2015 |
Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma.
Topics: Adult; Antimetabolites, Antineoplastic; Attention; Bone Neoplasms; Case-Control Studies; Cognition; Cognition Disorders; Cross-Sectional Studies; Emotions; Executive Function; Female; Humans; Male; Memory; Methotrexate; Middle Aged; Neurotoxicity Syndromes; Osteosarcoma; Quality of Life; Risk Assessment; Risk Factors; Survivors; Time Factors; Treatment Outcome; United States | 2016 |
For Patients With Cancer, Cure Is Not Enough.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Cognition; Cognition Disorders; Female; Hospitalization; Humans; Male; Methotrexate; Neoplasms; Neurotoxicity Syndromes; Osteosarcoma; Survivors | 2016 |
Clinical Reasoning: A 71-year-old man with rapidly progressive dementia.
Topics: Aged; Brain Neoplasms; Cognition Disorders; Critical Care; Dementia; Diagnosis, Differential; Disease Progression; Humans; Lymphoma; Male; Methotrexate; Physical Examination; Treatment Outcome | 2016 |
Environmental enrichment protects against cognitive impairment following chemotherapy in an animal model.
Topics: Animals; Antimetabolites, Antineoplastic; Cognition Disorders; Disease Models, Animal; Drug Therapy; Environment; Female; Fluorouracil; Hippocampus; Methotrexate; Neurogenesis; Rats; Rats, Long-Evans; Spatial Memory | 2016 |
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Behavior Rating Scale; Child; Child Behavior Disorders; Cognition Disorders; Cranial Irradiation; Dexamethasone; Diffusion Tensor Imaging; Female; Humans; Injections, Spinal; Intelligence Tests; Leukoencephalopathies; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory, Short-Term; Methotrexate; Neuropsychological Tests; Observational Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Survivors; Treatment Outcome; White Matter | 2016 |
Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Treatment Outcome; Young Adult | 2017 |
A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Auditory Perception; Cognition Disorders; Electroencephalography; Electrophysiology; Evoked Potentials; Evoked Potentials, Auditory; Fear; Fluorouracil; Male; Methotrexate; Mice; Mice, Inbred C57BL; Neurotoxicity Syndromes; Recognition, Psychology | 2008 |
Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats.
Topics: Analysis of Variance; Animals; Antimetabolites, Antineoplastic; Association Learning; Cell Death; Cell Proliferation; Cognition; Cognition Disorders; Conditioning, Classical; Disease Models, Animal; Fear; Follow-Up Studies; Hippocampus; Maze Learning; Methotrexate; Rats; Rats, Wistar; Time Factors | 2009 |
Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.
Topics: Animals; Antimetabolites, Antineoplastic; Behavior, Animal; Cisterna Magna; Cognition Disorders; Disease Models, Animal; Folic Acid; Folic Acid Antagonists; Homocysteine; Inflammation Mediators; Injections, Spinal; Male; Memory Disorders; Methotrexate; Motor Activity; Neuropsychological Tests; Psychomotor Performance; Rats; Rats, Long-Evans; Recognition, Psychology; Time Factors | 2010 |
A case of normal-pressure hydrocephalus associated with rheumatoid arthritis.
Topics: Activities of Daily Living; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Brain; Cognition Disorders; Female; Humans; Hydrocephalus, Normal Pressure; Magnetic Resonance Imaging; Methotrexate; Prednisone; Treatment Outcome | 2010 |
Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents.
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Cognition Disorders; Discrimination Learning; Discrimination, Psychological; Injections, Intraperitoneal; Male; Maze Learning; Memory; Methotrexate; Rats; Rats, Wistar; Recognition, Psychology | 2010 |
Autism Speaks: meeting on folate metabolism and Autism spectrum disorders, March 19-20, 2009, Washington, DC.
Topics: Autistic Disorder; Biological Transport; Brain; Cognition Disorders; District of Columbia; Folic Acid; Genomic Instability; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, N-Methyl-D-Aspartate; Vitamin B 12 | 2011 |
Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Cognition Disorders; Cues; Disease Models, Animal; Donepezil; Female; Fluorouracil; Indans; Maze Learning; Memory; Methotrexate; Mice; Mice, Inbred BALB C; Nootropic Agents; Piperidines; Space Perception; Time Factors | 2011 |
Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist.
Topics: Animals; Cognition Disorders; Dextromethorphan; Disease Models, Animal; Excitatory Amino Acid Antagonists; Folic Acid; Glutamic Acid; Homocysteine; Humans; Injections, Spinal; Male; Memory Disorders; Methotrexate; Rats; Rats, Long-Evans; Recognition, Psychology | 2011 |
Cognitive functions in primary CNS lymphoma after single or combined modality regimens.
Topics: Adult; Aged; Aged, 80 and over; Brain; Central Nervous System Neoplasms; Cognition; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Female; Follow-Up Studies; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neuropsychological Tests; Quality of Life | 2012 |
Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Cerebellar Neoplasms; Child; Child, Preschool; Cognition Disorders; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Maintenance Chemotherapy; Male; Medulloblastoma; Methotrexate; Myelography; Nervous System Diseases; Neuropsychological Tests; Radiotherapy Dosage; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Young Adult | 2012 |
Intellectual functioning of childhood leukemia survivors--relation to Tau protein--a marker of white matter injury.
Topics: Adolescent; Antineoplastic Agents; Biomarkers; Brain Injuries; Child; Child, Preschool; Cognition Disorders; Female; Humans; Intelligence; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; tau Proteins | 2012 |
Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
Topics: Antibiotic Prophylaxis; Antimetabolites, Antineoplastic; Atrophy; Brain; Brain Neoplasms; Child; Child, Preschool; Cognition Disorders; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Intelligence Tests; Magnetic Resonance Imaging; Male; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Injuries; Radiotherapy, Adjuvant; Survival Rate; Tomography, X-Ray Computed | 2002 |
Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cognition; Cognition Disorders; Female; Humans; Infusions, Intravenous; Injections, Intraventricular; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neuropsychological Tests | 2003 |
Neurocognitive outcomes in primary CNS lymphoma (PCNSL).
Topics: Aged; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Comorbidity; Cranial Irradiation; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Invasiveness; Radiation Injuries; Treatment Outcome | 2004 |
Cognitive functions in survivors of primary central nervous system lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Attention; Brain; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Memory; Methotrexate; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Remission Induction; Survivors | 2004 |
Cognitive status and quality of life after treatment for primary CNS lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Carmustine; Case-Control Studies; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Hydrocortisone; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Teniposide | 2004 |
Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cognition Disorders; Cyclophosphamide; Depression; Fatigue; Female; Fluorouracil; Humans; Mastectomy; Mastectomy, Segmental; Methotrexate; Middle Aged; Motivation; Prospective Studies; Quality of Life | 2005 |
Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol.
Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain; Child; Child, Preschool; Cognition Disorders; Cohort Studies; Cytarabine; Female; Hematinics; Humans; Hydrocortisone; Leucovorin; Male; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Wechsler Scales | 2005 |
Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy.
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Cognition Disorders; Cyclophosphamide; Electroencephalography; Evoked Potentials; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neuropsychological Tests; Neurotoxicity Syndromes; Reaction Time | 2005 |
Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cognition Disorders; Cytarabine; Drug Screening Assays, Antitumor; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome | 2003 |
Comparison of long-term neurocognitive outcomes in young children with acute lymphatic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Topics: Child; Child, Preschool; Cognition; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Incidence; Infusions, Intravenous; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Risk Assessment; Time Factors | 2007 |
Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Brain Damage, Chronic; Brain Edema; Cerebral Arteries; Cognition Disorders; Dexamethasone; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Female; Gliosis; Glucocorticoids; Humans; Methotrexate; Middle Aged; Nerve Fibers, Myelinated; Neurodegenerative Diseases; Telencephalon; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Weight; Cell Proliferation; Cognition Disorders; Discrimination, Psychological; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hippocampus; Ki-67 Antigen; Male; Maze Learning; Methotrexate; Pattern Recognition, Visual; Rats; Rats, Wistar; Reaction Time | 2008 |
[Necrotizing systemic sarcoidosis with pulmonary and central nervous system involvement].
Topics: Adult; Antitubercular Agents; Brain Diseases; Cognition Disorders; Diagnostic Errors; Epilepsy, Tonic-Clonic; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Necrosis; Prednisone; Remission Induction; Sarcoidosis; Sarcoidosis, Pulmonary; Tuberculosis, Pulmonary; Urinary Incontinence; Vertigo | 2008 |
Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia.
Topics: Analysis of Variance; Antimetabolites, Antineoplastic; Child; Chromatography, Gas; Cognition Disorders; Female; Humans; Intelligence Tests; Male; Methotrexate; NAD; Oxidation-Reduction; Palmitic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Psychomotor Performance; Risk Factors; Statistics, Nonparametric; Stearic Acids | 2008 |
Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neuropsychological Tests; Treatment Outcome | 2008 |
Neuropsychological and neurological outcome after relapse of lymphoblastic leukaemia.
Topics: Age Factors; Brain; Child; Child, Preschool; Cognition Disorders; Cranial Irradiation; Developmental Disabilities; Education; Female; Growth Disorders; Humans; Infant; Intelligence; Leukemia, Lymphoid; Leukemic Infiltration; Male; Methotrexate; Nervous System Diseases; Radiation Injuries; Radiotherapy; Recurrence; Whole-Body Irradiation | 1994 |
Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer.
Topics: Absenteeism; Adolescent; Analysis of Variance; Central Nervous System Neoplasms; Child; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Humans; Injections, Spinal; Intelligence; Intelligence Tests; Leukemia; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasms; Neuropsychological Tests | 1994 |
Cognitive late effect factors related to decision making and risk behaviors of cancer-surviving adolescents.
Topics: Adolescent; Antimetabolites, Antineoplastic; Cognition Disorders; Decision Making; Female; Humans; Male; Methotrexate; Neoplasms; Radiotherapy; Regression Analysis; Risk-Taking | 1997 |
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Developmental Disabilities; Female; Follow-Up Studies; Humans; Infant; Injections, Spinal; Leucovorin; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Movement Disorders; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Psychomotor Performance; Remission Induction; Risk; Socioeconomic Factors; Survivors; Vincristine | 1999 |
Primary central nervous system lymphoma: a clinicopathological study of 28 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lymphoma; Male; Methotrexate; Middle Aged; Spinal Cord Neoplasms; Survival Analysis; Time Factors | 2000 |
Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia.
Topics: Achievement; Adolescent; Antineoplastic Agents; Asthma; Brain; Child; Chronic Disease; Cognition Disorders; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Injections, Spinal; Intelligence; Intelligence Tests; Long-Term Care; Male; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index; Survivors | 2000 |
[Psychological and behavioral disorders with good outcome in neurosarcoidosis].
Topics: Adult; Antirheumatic Agents; Cognition Disorders; Drug Therapy, Combination; Facial Paralysis; Female; Humans; Hydroxychloroquine; Magnetic Resonance Imaging; Meningitis; Methotrexate; Nervous System Diseases; Neurocognitive Disorders; Paranoid Disorders; Prednisolone; Prognosis; Sarcoidosis; Treatment Outcome | 2001 |
[Sarcoidosis and progressive multifocal leukoencephalopathy].
Topics: Aged; Antiviral Agents; Brain Diseases; Cerebellum; Cognition Disorders; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Methotrexate; Neuropsychological Tests; Occipital Lobe; Papillomavirus Infections; Parietal Lobe; Sarcoidosis; Severity of Illness Index | 2001 |
5. Report on workshop: Primary CNS lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Gene Rearrangement; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Methotrexate; Radiation Injuries; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome | 2001 |
CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Attention; Brain Neoplasms; Central Nervous System; Child; Child, Preschool; Cognition Disorders; Cranial Irradiation; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Intelligence Tests; Male; Memory Disorders; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 2002 |
No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Attention; Child, Preschool; Cognition Disorders; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Spinal; Learning Disabilities; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Netherlands; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Survivors; Teniposide; Treatment Outcome; Vincristine | 2002 |
Pediatric acute lymphoblastic leukemia: redefining outcomes.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Attention; Child; Child, Preschool; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Dexamethasone; Drug Administration Routes; Humans; Hydrocortisone; Infant; Learning Disabilities; Memory Disorders; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survivors; Treatment Outcome | 2002 |
Neuropsychologic impairment in adult bone marrow transplant candidates.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Attention; Bone Marrow Transplantation; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Cranial Irradiation; Cytarabine; Female; Humans; Leukemia; Lymphoma; Male; Memory; Methotrexate; Middle Aged; Neuropsychology; Psychomotor Performance; Regression Analysis; Whole-Body Irradiation | 1992 |
An animal model to study toxicity of central nervous system therapy for childhood acute lymphoblastic leukemia: effects on behavior.
Topics: Animals; Behavior, Animal; Brain; Cognition Disorders; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Radiotherapy; Rats; Rats, Inbred Strains; Sex Characteristics | 1990 |
Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cognition Disorders; Communication Disorders; Cytarabine; Female; Follow-Up Studies; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Neuropsychological Tests; Prednisone; Tomography, X-Ray Computed; Vincristine | 1985 |
Encephalopathy in acute leukaemia associated with methotrexate therapy.
Topics: Acute Disease; Adult; Ataxia; Brain Diseases; Child; Child, Preschool; Cognition Disorders; Electroencephalography; Epilepsy; Female; Folic Acid; Humans; Injections, Spinal; Leukemia; Leukemia, Lymphoid; Male; Meninges; Methotrexate; Psychoses, Substance-Induced; Tremor | 1972 |
Central nervous system involvement in Burkitt's lymphoma.
Topics: Brain Neoplasms; Burkitt Lymphoma; Central Nervous System Diseases; Cerebrospinal Fluid; Cognition Disorders; Cyclophosphamide; Cytarabine; Folic Acid; Humans; Injections, Spinal; Lymphocytosis; Methotrexate; Neoplasm Metastasis; Paraplegia; Vincristine | 1970 |